Small pharma obtains final order approving arrangement

London & toronto--(business wire)--small pharma inc. (tsxv: dmt) (otcqb: dmttf) (“small pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and cybin inc. (nyse american:cybn) (neo:cybn) (“cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, are pleased to announce that small pharma has obtained a final order of t.
CYBN Ratings Summary
CYBN Quant Ranking